News
Orforglipron: What to Know About Eli Lilly’s New Weight Loss Pill for Obesity
Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials. The weight loss pill also significantly improved heart health markers like cholesterol and blood pressure.
"Forever" PFAS chemicals might hamper a teenager's ability to drop excess weight, even if they've undergone weight-loss ...
9h
The ‘Nordic diet’ can help you lose weight and prevent heart attacks — stock up on these foods
By avoiding processed junk, saturated fats and high-cholesterol meats while loading up on fiber-rich whole foods, studies ...
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...
Obese women who participate in weight loss programmes before starting in vitro fertilisation (IVF) are 47% more likely to ...
New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an increased risk of rare eye conditions.
There's likely no direct link between itchy skin and weight loss. However, if you're experiencing itchy skin while losing ...
The Hunting Wives' actress Chrissy Metz gets candid in a new cover story for PEOPLE on her thoughts about using weight loss ...
A diet rich in fruit, vegetables, healthy fats, lean proteins and some whole grains will serve you best in terms of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback